POSTER: MPN-524 Reductions in Indolent Systemic Mastocytosis Biomarker Burden with Avapritinib in the Registrational, Double-Blind, Placebo-Controlled PIONEER Trial
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2023)
Key words
myeloproliferative neoplasm,avapritinib,KIT D816V,systemic mastocytosis,tyrosine kinase inhibitor,C-KIT
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined